• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液腺嗜酸性细胞病变:形态学、免疫组织化学及分子学研究结果

Oncocytic Lesions of Salivary Glands: Morphological, Immunohistochemical, and Molecular Findings.

作者信息

Parmar Riddhi, Kalaria Amankumar N, Patel Keval A

机构信息

Department of Pathology, All India Institute of Medical Sciences, Rajkot, Rajkot, IND.

Department of Pathology, Swaminarayan Institute of Medical Sciences & Research, Kalol, IND.

出版信息

Cureus. 2024 Apr 29;16(4):e59328. doi: 10.7759/cureus.59328. eCollection 2024 Apr.

DOI:10.7759/cureus.59328
PMID:38817461
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11137436/
Abstract

The fifth edition of the World Health Organization (WHO) classification introduces new diagnostic methods based on genetic alterations, providing insight into the molecular basis of lesions. As a result, the classification system has evolved, new entities have been introduced, and existing entities have been reclassified. Oncocytic lesions of salivary glands are a group of neoplastic conditions characterized by the presence of oncocytic cells. These lesions present a diagnostic challenge due to their overlapping histological features. Therefore, a comprehensive evaluation, including morphological, immunohistochemical, and molecular analysis, is crucial for accurate diagnosis and appropriate management. Accurate classification of salivary gland pathologies is essential for selecting the appropriate treatment methods and predicting outcomes. The introduction of new therapeutic approaches, such as targeted therapies for malignant salivary gland tumors, has improved patient outcomes. However, to effectively implement these therapies in clinical practice, a clear classification of lesions is necessary.

摘要

世界卫生组织(WHO)分类的第五版引入了基于基因改变的新诊断方法,从而深入了解病变的分子基础。因此,分类系统不断演变,引入了新的实体,并对现有实体进行了重新分类。涎腺嗜酸性细胞病变是一组以嗜酸性细胞存在为特征的肿瘤性疾病。这些病变因其组织学特征重叠而带来诊断挑战。因此,包括形态学、免疫组织化学和分子分析在内的综合评估对于准确诊断和恰当处理至关重要。涎腺病理学的准确分类对于选择合适的治疗方法和预测预后至关重要。新治疗方法的引入,如针对恶性涎腺肿瘤的靶向治疗,改善了患者的预后。然而,要在临床实践中有效实施这些治疗,明确的病变分类是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/de9197f2b311/cureus-0016-00000059328-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/0c2eca768ca7/cureus-0016-00000059328-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/1a6887b0b17a/cureus-0016-00000059328-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/776a7de746d8/cureus-0016-00000059328-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/c58f07fd47bb/cureus-0016-00000059328-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/36d6e7f1a6a0/cureus-0016-00000059328-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/4581742b7bc0/cureus-0016-00000059328-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/de9197f2b311/cureus-0016-00000059328-i07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/0c2eca768ca7/cureus-0016-00000059328-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/1a6887b0b17a/cureus-0016-00000059328-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/776a7de746d8/cureus-0016-00000059328-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/c58f07fd47bb/cureus-0016-00000059328-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/36d6e7f1a6a0/cureus-0016-00000059328-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/4581742b7bc0/cureus-0016-00000059328-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a322/11137436/de9197f2b311/cureus-0016-00000059328-i07.jpg

相似文献

1
Oncocytic Lesions of Salivary Glands: Morphological, Immunohistochemical, and Molecular Findings.唾液腺嗜酸性细胞病变:形态学、免疫组织化学及分子学研究结果
Cureus. 2024 Apr 29;16(4):e59328. doi: 10.7759/cureus.59328. eCollection 2024 Apr.
2
Salivary gland pathologies: evolution in classification and association with unique genetic alterations.唾液腺疾病:分类演变及与独特遗传改变的关联。
Eur Arch Otorhinolaryngol. 2023 Nov;280(11):4739-4750. doi: 10.1007/s00405-023-08110-w. Epub 2023 Jul 13.
3
Oncocytic Lesions of Salivary Glands with Morphological and Immunohistochemical Findings.唾液腺嗜酸性细胞病变的形态学及免疫组化研究结果
Sisli Etfal Hastan Tip Bul. 2020 Mar 24;54(1):88-93. doi: 10.14744/SEMB.2018.04935. eCollection 2020.
4
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.世界卫生组织头颈部肿瘤分类第 5 版更新:唾液腺。
Head Neck Pathol. 2022 Mar;16(1):40-53. doi: 10.1007/s12105-022-01420-1. Epub 2022 Mar 21.
5
The key radiologic and cytomorphologic features of oncocytic and oncocytoid lesions of the salivary gland.唾液腺嗜酸性细胞及嗜酸性细胞样病变的关键放射学和细胞形态学特征。
Diagn Cytopathol. 2019 Jun;47(6):617-636. doi: 10.1002/dc.24175. Epub 2019 Mar 26.
6
Overview of the 2022 WHO Classification of Thyroid Neoplasms.2022 年世卫组织甲状腺肿瘤分类概述。
Endocr Pathol. 2022 Mar;33(1):27-63. doi: 10.1007/s12022-022-09707-3. Epub 2022 Mar 14.
7
Top Ten Oncocytic Head and Neck Lesions to Contemplate.十大需考虑的嗜酸性细胞头颈部病变。
Head Neck Pathol. 2023 Mar;17(1):53-65. doi: 10.1007/s12105-022-01520-y. Epub 2023 Mar 16.
8
Oncocytic mucoepidermoid carcinoma (OMEC) of the parotid gland in a 12-year-old patient: A diagnostic challenge on cytology.12 岁患者腮腺的嗜酸细胞型黏液表皮样癌(OMEC):细胞学诊断的挑战。
Diagn Cytopathol. 2021 Feb;49(2):E60-E64. doi: 10.1002/dc.24581. Epub 2020 Aug 15.
9
Oncocytic mucoepidermoid carcinoma of the salivary glands.涎腺嗜酸性细胞黏液表皮样癌
Am J Surg Pathol. 1999 May;23(5):523-9. doi: 10.1097/00000478-199905000-00005.
10
Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification.甲状腺肿瘤的分子病理学:关于最新世界卫生组织分类需理解的要点
Biomedicines. 2024 Mar 22;12(4):712. doi: 10.3390/biomedicines12040712.

引用本文的文献

1
Multiple Oncocytomas of the Minor Salivary Glands Presenting as a Parapharyngeal Tumour: With Review of Literature.表现为咽旁肿瘤的小涎腺多形性腺瘤:附文献复习
Indian J Otolaryngol Head Neck Surg. 2025 Apr;77(4):1933-1938. doi: 10.1007/s12070-025-05424-5. Epub 2025 Mar 24.
2
Oncocytic Tumors in the Salivary Gland: Cytopathological, Pathological, and Molecular Features.涎腺嗜酸性细胞瘤:细胞病理学、病理学及分子特征
Acta Cytol. 2025 Apr 1:1-12. doi: 10.1159/000544802.
3
Salivary Gland Oncocytomas. A Systematic Review.涎腺嗜酸细胞瘤。系统综述。

本文引用的文献

1
Management of Salivary Gland Malignancy: ASCO Guideline.唾液腺癌的治疗管理:ASCO 指南。
J Clin Oncol. 2021 Jun 10;39(17):1909-1941. doi: 10.1200/JCO.21.00449. Epub 2021 Apr 26.
2
Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.唾液腺肿瘤的分子病理学:诊断、预后和预测视角。
Adv Anat Pathol. 2021 Mar 1;28(2):81-93. doi: 10.1097/PAP.0000000000000291.
3
Molecular and Cellular Modelling of Salivary Gland Tumors Open New Landscapes in Diagnosis and Treatment.唾液腺肿瘤的分子和细胞建模为诊断和治疗开辟了新前景。
Head Neck Pathol. 2024 Nov 30;18(1):126. doi: 10.1007/s12105-024-01730-6.
Cancers (Basel). 2020 Oct 24;12(11):3107. doi: 10.3390/cancers12113107.
4
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer.帕博利珠单抗和伏立诺他治疗复发性转移性头颈部鳞状细胞癌和唾液腺癌的 II 期临床试验。
Clin Cancer Res. 2020 Feb 15;26(4):837-845. doi: 10.1158/1078-0432.CCR-19-2214. Epub 2019 Dec 3.
5
Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma: Proposal of a Novel Histologic Risk Stratification Model.唾液腺癌组织学指标的预后意义:提出一种新的组织学危险分层模型。
Am J Surg Pathol. 2020 Apr;44(4):526-535. doi: 10.1097/PAS.0000000000001413.
6
Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.全面分子分析揭示唾液腺癌的新治疗靶点。
Cancer Med. 2019 Dec;8(17):7322-7329. doi: 10.1002/cam4.2602. Epub 2019 Oct 14.
7
Salivary duct carcinoma: A case report of oncocytic variant with possible treatment implications and review of literature.唾液腺癌:一例具有治疗意义的嗜酸细胞变异型病例报告,并文献复习。
Pathol Res Pract. 2019 Oct;215(10):152549. doi: 10.1016/j.prp.2019.152549. Epub 2019 Aug 24.
8
Contemporary Management of Benign and Malignant Parotid Tumors.腮腺良恶性肿瘤的当代管理
Front Surg. 2018 May 11;5:39. doi: 10.3389/fsurg.2018.00039. eCollection 2018.
9
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.帕博利珠单抗治疗晚期唾液腺癌:1b期KEYNOTE-028研究结果
Am J Clin Oncol. 2018 Nov;41(11):1083-1088. doi: 10.1097/COC.0000000000000429.
10
Oncocytes in Mucoepidermoid Carcinoma of the Palate: Diagnostic Challenges.腭部黏液表皮样癌中的嗜酸性细胞:诊断挑战
Case Rep Dent. 2017;2017:5741821. doi: 10.1155/2017/5741821. Epub 2017 Dec 28.